To explain that, two additional assumptions were made and tested: leptin and/or adiponectin could be able to modify, by a systemic effect, angiogenesis events and hyperleptinemia could affect cancer treatment effectiveness in obesity situation. The gene discussed is ADIPOQ; the disease is cancer.